Stella Pharma Company Description

Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals.

The company develops drugs for boron neutron capture therapy (BNCT). Its product includes SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma and meningioma, and malignant melanoma and angiosarcoma.

The company was incorporated in 2007 and is headquartered in Osaka, Japan.

Stella Pharma Corporation

Country	Japan
Founded	2007
Industry	Biotechnology
Sector	Healthcare
Employees	44
CEO	Koki Uehara

Contact Details

Address: ORIX Kouraibashi Building Osaka, 541-0043 Japan
Phone	81 6 4707 1516
Website	stella-pharma.co.jp

Stock Details

Ticker Symbol	4888
Exchange	Tokyo Stock Exchange
Stock Type	Common Stock
Fiscal Year	April - March
Reporting Currency	JPY
ISIN Number	JP3399680002
SIC Code	2836

Key Executives

Name	Position
Koki Uehara	Chief Executive Officer